The Prostate Health Education Network: Prostate Health Education and Awareness

Clinical Trials

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer Number: NCT01492972 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Proton Collaborative Group Sponsor Trial Information Trial Location(s) and Contact(s):	Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer Number: NCT01581749 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 4 Sponsor(s): Albert DeNittis\|Main Line Health Sponsor Trial Information Trial Location(s) and Contact(s):
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts Number: NCT02266745 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Promontory Therapeutics Inc. Sponsor Trial Information Trial Location(s) and Contact(s):	68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer Number: NCT03113617 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Andrei Iagaru\|Stanford University Sponsor Trial Information Trial Location(s) and Contact(s):
Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C) Number: NCT03525262 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Texas Southwestern Medical Center\|Boston Scientific Corporation Sponsor Trial Information Trial Location(s) and Contact(s):	Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy Number: NCT03580499 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University Sponsor Trial Information Trial Location(s) and Contact(s):
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer Number: NCT03654638 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Ohio State University Comprehensive Cancer Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	4-aminopyridine Treatment for Nerve Injury Number: NCT03701581 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2\|Phase 3 Sponsor(s): University of Rochester\|Milton S. Hershey Medical Center Sponsor Trial Information Trial Location(s) and Contact(s):
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer Number: NCT03772834 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2\|Phase 3 Sponsor(s): M.D. Anderson Cancer Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer Number: NCT03808077 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Memorial Sloan Kettering Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s):
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy Number: NCT03824652 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Stephen Freedland\|California Walnut Commission\|Cedars-Sinai Medical Center Sponsor Trial Information Trial Location(s) and Contact(s):	INTREPId (INTermediate Risk Erection PreservatIon Trial) Number: NCT04025372 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Dana-Farber Cancer Institute\|Bayer\|Decipher Biosciences Sponsor Trial Information Trial Location(s) and Contact(s):
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer Number: NCT04194554 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): University of Michigan Rogel Cancer Center\|Janssen Scientific Affairs, LLC Sponsor Trial Information Trial Location(s) and Contact(s):	Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer Number: NCT04298983 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Alabama at Birmingham Sponsor Trial Information Trial Location(s) and Contact(s):
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer Number: NCT04301414 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Matthew Dallos\|Bristol-Myers Squibb\|Ferring Pharmaceuticals\|Columbia University Sponsor Trial Information Trial Location(s) and Contact(s):	Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) Number: NCT04349501 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of California, San Diego Sponsor Trial Information Trial Location(s) and Contact(s):
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Number: NCT04373564 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 4 Sponsor(s): Guerbet\|Bayer AG (Sponsor)\|Bracco (Sponsor)\|GEHC (Sponsor) Sponsor Trial Information Trial Location(s) and Contact(s):	High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy Number: NCT04461509 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Alessandro D'Agnolo\|Progenics Pharmaceuticals, Inc.\|Cedars-Sinai Medical Center Sponsor Trial Information Trial Location(s) and Contact(s):
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer Number: NCT04465500 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Virginia Sponsor Trial Information Trial Location(s) and Contact(s):	White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA Number: NCT04519879 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): City of Hope Medical Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland Number: NCT04530552 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors Number: NCT04557449 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Pfizer Sponsor Trial Information Trial Location(s) and Contact(s):
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer Number: NCT04600336 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies Number: NCT04644068 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): AstraZeneca Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of Tarlatamab (AMG 757) in Participants With Neuroendocrine Prostate Cancer Number: NCT04702737 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Amgen Sponsor Trial Information Trial Location(s) and Contact(s):	An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC Number: NCT04720157 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Novartis Pharmaceuticals\|Alliance Foundation Trials, LLC.\|RTOG Foundation, Inc.\|Novartis Sponsor Trial Information Trial Location(s) and Contact(s):
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer Number: NCT04734730 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): City of Hope Medical Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	Study of TT-00420 Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors Number: NCT04742959 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): TransThera Sciences (Nanjing), Inc. Sponsor Trial Information Trial Location(s) and Contact(s):
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer Number: NCT04743934 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Andrew McDonald\|University of Alabama at Birmingham Sponsor Trial Information Trial Location(s) and Contact(s):	An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer Number: NCT04777071 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Washington Sponsor Trial Information Trial Location(s) and Contact(s):
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer Number: NCT04787744 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2\|Phase 3 Sponsor(s): VA Office of Research and Development Sponsor Trial Information Trial Location(s) and Contact(s):	Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer Number: NCT04842890 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): The New York Proton Center Sponsor Trial Information Trial Location(s) and Contact(s):
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization Number: NCT04879940 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute Sponsor Trial Information Trial Location(s) and Contact(s):	Androgen Deprivation, With or Without pTVG-AR, and With or Without Nivolumab, in Patients With Newly Diagnosed, High-Risk Prostate Cancer Number: NCT04989946 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): University of Wisconsin, Madison\|Madison Vaccines, Inc\|United States Department of Defense Sponsor Trial Information Trial Location(s) and Contact(s):
Insulin Resistance and Androgen Deprivation Therapy Number: NCT04995978 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): St. Louis University Sponsor Trial Information Trial Location(s) and Contact(s):	A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer Number: NCT04997018 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Memorial Sloan Kettering Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s):
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types Number: NCT05000294 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): University of Florida\|Genentech, Inc.\|Aveo Oncology Pharmaceuticals Sponsor Trial Information Trial Location(s) and Contact(s):	High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Number: NCT05011383 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): VA Office of Research and Development Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer Number: NCT05079698 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Memorial Sloan Kettering Cancer Center\|Novartis Pharmaceuticals Sponsor Trial Information Trial Location(s) and Contact(s):	Pioglitazone and Insulin Resistance in ADT Number: NCT05098327 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): State University of New York at Buffalo Sponsor Trial Information Trial Location(s) and Contact(s):
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer Number: NCT05189457 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute\|BeiGene Sponsor Trial Information Trial Location(s) and Contact(s):	68Ga-PSMA-11 PET in Patients With Prostate Cancer Number: NCT05197257 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): University of Colorado, Denver Sponsor Trial Information Trial Location(s) and Contact(s):

Total: 42 Clinical Trials

PHEN,Inc. © 2022 All rights reserved